Anticoagulant Reversal Drugs Market 2027 By Product, End User | The Insight Partners

Anticoagulant Reversal Drugs Market to 2027 - Global Analysis and Forecasts by Product (Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, AndeXXa); End User (Hospital Pharmacies, Retail Pharmacies, Others)

Report Code: TIPRE00004954 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Anticoagulant Reversal Drugs are needed for reversal effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding.

MARKET DYNAMICS
The Anticoagulant Reversal Drugs market is anticipated to grow in the forecast, owing to the factors such as growing prevalence of atrial fibrillation, increasing prevalence of intracranial hemorrhages and gastrointestinal hemorrhages, introduction of novel technology to certain specific drugs, growing focus on the development of specific drugs, strong pipeline of drugs, and significant opportunities in the emerging market. Nevertheless, risk associated with the reversal of anticoagulation and challenges in the development of anticoagulant drugs is expected to hamper the market growth during the forecast period.

MARKET SCOPE
The "Global Anticoagulant Reversal Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of Anticoagulant Reversal Drugs market with detailed market segmentation by Product, End User and geography. The global Anticoagulant Reversal Drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Anticoagulant Reversal Drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global Anticoagulant Reversal Drugs market is segmented on the basis of Product and End User. Based on Product the market is segmented into Prothrombin Complex Concentrates, Vitamin K, Protamine, Tranexamic Acid, Idarucizumab, and AndeXXa. Based on End User the market is segmented into Hospital Pharmacies, Retail Pharmacies, Others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Anticoagulant Reversal Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Anticoagulant Reversal Drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Anticoagulant Reversal Drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Anticoagulant Reversal Drugs market in these regions.

MARKET PLAYERS
The reports cover key developments in the Anticoagulant Reversal Drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Anticoagulant Reversal Drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Anticoagulant Reversal Drugs market in the global market. Below mentioned is the list of few companies engaged in the Anticoagulant Reversal Drugs market.

The report also includes the profiles of Anticoagulant Reversal Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Boehringer Ingelheim GmbH
  • Fresenius Kabi AG
  • Pfizer, Inc.
  • Bausch Health Companies, Inc.
  • Amneal Pharmaceuticals, Inc.
  • Perosphere Pharmaceuticals, Inc.
  • Ferring Pharmaceuticals
  • Portola Pharmaceuticals, Inc.
  • CSL Behring Limited
  • Octapharma AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Anticoagulant Reversal Drugs Market - By Product
1.3.2 Anticoagulant Reversal Drugs Market - By End User
1.3.3 Anticoagulant Reversal Drugs Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTICOAGULANT REVERSAL DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTICOAGULANT REVERSAL DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTICOAGULANT REVERSAL DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTICOAGULANT REVERSAL DRUGS - GLOBAL MARKET OVERVIEW
6.2. ANTICOAGULANT REVERSAL DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTICOAGULANT REVERSAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. PROTHROMBIN COMPLEX CONCENTRATES
7.3.1. Overview
7.3.2. Prothrombin Complex Concentrates Market Forecast and Analysis
7.4. VITAMIN K
7.4.1. Overview
7.4.2. Vitamin K Market Forecast and Analysis
7.5. PROTAMINE
7.5.1. Overview
7.5.2. Protamine Market Forecast and Analysis
7.6. TRANEXAMIC ACID
7.6.1. Overview
7.6.2. Tranexamic Acid Market Forecast and Analysis
7.7. IDARUCIZUMAB
7.7.1. Overview
7.7.2. Idarucizumab Market Forecast and Analysis
7.8. ANDEXXA
7.8.1. Overview
7.8.2. AndeXXa Market Forecast and Analysis
8. ANTICOAGULANT REVERSAL DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACIES
8.3.1. Overview
8.3.2. Hospital Pharmacies Market Forecast and Analysis
8.4. RETAIL PHARMACIES
8.4.1. Overview
8.4.2. Retail Pharmacies Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis
9. ANTICOAGULANT REVERSAL DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Anticoagulant Reversal Drugs Market Overview
9.1.2 North America Anticoagulant Reversal Drugs Market Forecasts and Analysis
9.1.3 North America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By End User
9.1.5 North America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Anticoagulant Reversal Drugs Market
9.1.5.1.1 United States Anticoagulant Reversal Drugs Market by Product
9.1.5.1.2 United States Anticoagulant Reversal Drugs Market by End User
9.1.5.2 Canada Anticoagulant Reversal Drugs Market
9.1.5.2.1 Canada Anticoagulant Reversal Drugs Market by Product
9.1.5.2.2 Canada Anticoagulant Reversal Drugs Market by End User
9.1.5.3 Mexico Anticoagulant Reversal Drugs Market
9.1.5.3.1 Mexico Anticoagulant Reversal Drugs Market by Product
9.1.5.3.2 Mexico Anticoagulant Reversal Drugs Market by End User
9.2. EUROPE
9.2.1 Europe Anticoagulant Reversal Drugs Market Overview
9.2.2 Europe Anticoagulant Reversal Drugs Market Forecasts and Analysis
9.2.3 Europe Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Anticoagulant Reversal Drugs Market Forecasts and Analysis - By End User
9.2.5 Europe Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Anticoagulant Reversal Drugs Market
9.2.5.1.1 Germany Anticoagulant Reversal Drugs Market by Product
9.2.5.1.2 Germany Anticoagulant Reversal Drugs Market by End User
9.2.5.2 France Anticoagulant Reversal Drugs Market
9.2.5.2.1 France Anticoagulant Reversal Drugs Market by Product
9.2.5.2.2 France Anticoagulant Reversal Drugs Market by End User
9.2.5.3 Italy Anticoagulant Reversal Drugs Market
9.2.5.3.1 Italy Anticoagulant Reversal Drugs Market by Product
9.2.5.3.2 Italy Anticoagulant Reversal Drugs Market by End User
9.2.5.4 Spain Anticoagulant Reversal Drugs Market
9.2.5.4.1 Spain Anticoagulant Reversal Drugs Market by Product
9.2.5.4.2 Spain Anticoagulant Reversal Drugs Market by End User
9.2.5.5 United Kingdom Anticoagulant Reversal Drugs Market
9.2.5.5.1 United Kingdom Anticoagulant Reversal Drugs Market by Product
9.2.5.5.2 United Kingdom Anticoagulant Reversal Drugs Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Anticoagulant Reversal Drugs Market Overview
9.3.2 Asia-Pacific Anticoagulant Reversal Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Anticoagulant Reversal Drugs Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Anticoagulant Reversal Drugs Market
9.3.5.1.1 Australia Anticoagulant Reversal Drugs Market by Product
9.3.5.1.2 Australia Anticoagulant Reversal Drugs Market by End User
9.3.5.2 China Anticoagulant Reversal Drugs Market
9.3.5.2.1 China Anticoagulant Reversal Drugs Market by Product
9.3.5.2.2 China Anticoagulant Reversal Drugs Market by End User
9.3.5.3 India Anticoagulant Reversal Drugs Market
9.3.5.3.1 India Anticoagulant Reversal Drugs Market by Product
9.3.5.3.2 India Anticoagulant Reversal Drugs Market by End User
9.3.5.4 Japan Anticoagulant Reversal Drugs Market
9.3.5.4.1 Japan Anticoagulant Reversal Drugs Market by Product
9.3.5.4.2 Japan Anticoagulant Reversal Drugs Market by End User
9.3.5.5 South Korea Anticoagulant Reversal Drugs Market
9.3.5.5.1 South Korea Anticoagulant Reversal Drugs Market by Product
9.3.5.5.2 South Korea Anticoagulant Reversal Drugs Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Anticoagulant Reversal Drugs Market Overview
9.4.2 Middle East and Africa Anticoagulant Reversal Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Anticoagulant Reversal Drugs Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Anticoagulant Reversal Drugs Market
9.4.5.1.1 South Africa Anticoagulant Reversal Drugs Market by Product
9.4.5.1.2 South Africa Anticoagulant Reversal Drugs Market by End User
9.4.5.2 Saudi Arabia Anticoagulant Reversal Drugs Market
9.4.5.2.1 Saudi Arabia Anticoagulant Reversal Drugs Market by Product
9.4.5.2.2 Saudi Arabia Anticoagulant Reversal Drugs Market by End User
9.4.5.3 U.A.E Anticoagulant Reversal Drugs Market
9.4.5.3.1 U.A.E Anticoagulant Reversal Drugs Market by Product
9.4.5.3.2 U.A.E Anticoagulant Reversal Drugs Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Anticoagulant Reversal Drugs Market Overview
9.5.2 South and Central America Anticoagulant Reversal Drugs Market Forecasts and Analysis
9.5.3 South and Central America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By End User
9.5.5 South and Central America Anticoagulant Reversal Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Anticoagulant Reversal Drugs Market
9.5.5.1.1 Brazil Anticoagulant Reversal Drugs Market by Product
9.5.5.1.2 Brazil Anticoagulant Reversal Drugs Market by End User
9.5.5.2 Argentina Anticoagulant Reversal Drugs Market
9.5.5.2.1 Argentina Anticoagulant Reversal Drugs Market by Product
9.5.5.2.2 Argentina Anticoagulant Reversal Drugs Market by End User
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ANTICOAGULANT REVERSAL DRUGS MARKET, KEY COMPANY PROFILES
11.1. BOEHRINGER INGELHEIM GMBH
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. FRESENIUS KABI AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. PFIZER, INC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BAUSCH HEALTH COMPANIES, INC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. AMNEAL PHARMACEUTICALS, INC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. PEROSPHERE PHARMACEUTICALS, INC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. FERRING PHARMACEUTICALS
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PORTOLA PHARMACEUTICALS, INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. CSL BEHRING LIMITED
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. OCTAPHARMA AG
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

- Boehringer Ingelheim GmbH
- Fresenius Kabi AG
- Pfizer, Inc.
- Bausch Health Companies, Inc.
- Amneal Pharmaceuticals, Inc.
- Perosphere Pharmaceuticals, Inc.
- Ferring Pharmaceuticals
- Portola Pharmaceuticals, Inc.
- CSL Behring Limited
- Octapharma AG